Evidence map›Paper›PMID 28485378›Full record

ArticleNature communications2017

Phf8 loss confers resistance to depression-like and anxiety-like behaviors in mice.

Ryan M Walsh, Erica Y Shen, Rosemary C Bagot, Anthony Anselmo, Yan Jiang, Behnam Javidfar, Gregory J Wojtkiewicz, Jennifer Cloutier, John W Chen, Ruslan Sadreyev and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. KDM7 Demethylases: Regulation, Function and Therapeutic Targeting.Advances in experimental medicine and biology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Variants inHGG advances · 2022
    Article
  19. Article
  20. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Ryan M WalshDepartment of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Erica Y ShenFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York City, New York 10029, USA.
Rosemary C BagotFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York City, New York 10029, USA.
Anthony AnselmoDepartment of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Yan JiangFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York City, New York 10029, USA.
Behnam JavidfarFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York City, New York 10029, USA.
Gregory J WojtkiewiczCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Jennifer CloutierDepartment of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
John W ChenCenter for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Ruslan SadreyevDepartment of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Eric J NestlerFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York City, New York 10029, USA.
Schahram AkbarianFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York City, New York 10029, USA.
Konrad HochedlingerDepartment of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Icahn School of Medicine at Mount Sinai · USHoward Hughes Medical Institute · USMassachusetts General Hospital · USAllen Institute for Brain Science · USCenter for Systems Biology · US

Funding

REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELSP50MH096890 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAMMINGA, CAROL A · 2012 to 2021
$20.2M
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral FellowsT32HL087735 · NHLBI · HARVARD UNIVERSITY · PI SCADDEN, DAVID T · 2008 to 2012
$1.7M
NHLBI NIH HHS T32 HL087735NIMH NIH HHS P50 MH096890
6 · The paper itself

Abstract

PHF8 is a histone demethylase with specificity for repressive modifications. While mutations of PHF8 have been associated with cognitive defects and cleft lip/palate, its role in mammalian development and physiology remains unexplored. Here, we have generated a Phf8 knockout allele in mice to examine the consequences of Phf8 loss for development and behaviour. Phf8 deficient mice neither display obvious developmental defects nor signs of cognitive impairment. However, we report a striking resiliency to stress-induced anxiety- and depression-like behaviour on loss of Phf8. We further observe misregulation of serotonin signalling within the prefrontal cortex of Phf8 deficient mice and identify the serotonin receptors Htr1a and Htr2a as direct targets of PHF8. Our results clarify the functional role of Phf8 in mammalian development and behaviour and establish a direct link between Phf8 expression and serotonin signalling, identifying this histone demethylase as a potential target for the treatment of anxiety and depression.

Indexed as

Behavior, AnimalResilience, PsychologicalAllelesAnimalsAnxietyCognitive DysfunctionDepressionGene DeletionHistone DemethylasesMiceMice, KnockoutMouse Embryonic Stem CellsPrefrontal CortexReceptors, SerotoninStress, PsychologicalTranscription FactorsHistone DemethylasesPHF8 protein, mouseReceptors, SerotoninTranscription Factors

Identifiers

PMID28485378
PMCPMC5436068
OpenAlexW2612442249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.